Holland & Knight Health Dose: May 16, 2023

HK
Holland & Knight

Contributor

Holland & Knight is a global law firm with nearly 2,000 lawyers in offices throughout the world. Our attorneys provide representation in litigation, business, real estate, healthcare and governmental law. Interdisciplinary practice groups and industry-based teams provide clients with access to attorneys throughout the firm, regardless of location.
Holland & Knight Health Dose is an in-depth weekly dose of legislative and regulatory insights to keep stakeholders abreast of happenings in Washington, D.C., impacting the health sector.
United States Food, Drugs, Healthcare, Life Sciences
To print this article, all you need is to be registered or login on Mondaq.com.

Holland & Knight Health Dose is an in-depth weekly dose of legislative and regulatory insights to keep stakeholders abreast of happenings in Washington, D.C., impacting the health sector.

This week's topics include:

  • This Week: Debt Limit Looms as Negotiations Continue
  • Energy and Commerce Committee to Mark Up 17 Bills
  • Senate Committee on HELP Advances PBM and Generic Drug Package
  • Senate HELP Committee Hosts Roundtable on Healthcare Workforce
  • House Republicans Call for Oversight of CMS's Innovation Center
  • House Energy and Commerce Committee Begins Work on PAHPA Reauthorization
  • CMS Releases Latest Unwinding Guidance
  • GAO Reports on 340B and Public Health Preparedness

Read the full Health Dose

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

Mondaq uses cookies on this website. By using our website you agree to our use of cookies as set out in our Privacy Policy.

Learn More